5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-PENTANOIC ACID

UNII:	JVN6L30QZK
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₂₅N₇O₅
Preferred Substance Name:	5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-PENTANOIC ACID
InChIKey:	FNDUYVQCZRSNAY-UHFFFAOYSA-N
GSRS Full Record:	JVN6L30QZK i

1807607-25-5
LINAGLIPTIN METABOLITE M504(2)
PENTANOIC ACID, 5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-

Common Chemistry
i
Inxight Drugs
i
PubChem
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

5-((7-(2-BUTYN-1-YL)-2,3,6,7-TETRAHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-2,6-DIOXO-1H-PURIN-8-YL)AMINO)-2-OXO-PENTANOIC ACID

Synonyms and Mappings

Resources